CiiTA Managing Partner to Speak at National Leadership Summit on 340B

PORTLAND, Ore. – April 25, 2016 — CiiTA founder and managing partner Jason Hardaway is invited to speak at the upcoming third-annual National Leadership Summit on 340B in Washington, D.C. on May 17, 2016. This summit is the annual opportunity for stakeholders to engage in meaningful and transparent dialogue to ensure the 340B program’s future viability and integrity.

Following last year’s National Leadership Summit on 340B, the administration released the long-anticipated mega-guidance, which proposed a number of important steps to strengthen the program. However, many questions remain unanswered, including whether the mega-guidance will be finalized.  This summit will continue the dialogue around the proposed mega-guidance, and Mr. Hardaway’s presentation will address key issues that manufacturers should understand.

For more information on the May 17 National Leadership Summit on 340B, click here. (https://www.340bleadershipsummit.org/page.asp?ID=29)

Jason Hardaway is a recognized expert on the federal 340B Program and a frequent presenter or panel member at 340B industry events.

CiiTA, LLC provides unique expertise and actionable market intelligence to pharmaceutical and biotechnology manufacturers participating in the 340B Drug Discount Program. We apply in-depth knowledge of 340B Program regulations and custom research to help manufacturers maintain strict compliance with Program guidelines while mitigating the financial risk of Program abuse.